Table 2.
Site | The Bronx, NY(2008) | Washington, D.C. (2009) | ||
---|---|---|---|---|
Number of HIV-Infected Patients in Care | Proportion of HIV-Infected Patients with VL Suppressed1 | Number of HIV-Infected Patients in Care | Proportion of HIV-Infected Patients with VL Suppressed1 | |
1 | 2,751 | 59% | 1,425 | 72% |
2 | 2,500* | 69% | 1,138 | 58% |
3 | 1,483 | 60% | 675 | 59% |
4 | 1,176 | 57% | 482 | 87% |
5 | 1,118 | 56% | 376 | 61% |
6 | 702 | 50% | 321 | 66% |
7 | 379 | 58% | 319 | 73% |
8 | 376 | 56% | 296 | 89% |
9 | 277 | 56% | 289 | 64% |
10 | 275 | 63% | 153 | 53% |
11 | 227 | 66% | 107 | 77% |
12 | 210 | 39% | 98 | 30% |
13 | 180 | 66% | 67 | 64% |
14 | 173 | 55% | 60 | 63% |
15 | 131 | 63% | 41 | 73% |
16 | 130* | 45% | 33 | 36% |
17 | 119 | 36% | 15 | 67% |
18 | 118 | 39% | 12 | 50% |
19 | 103 | 58% | 8 | 0% |
20 | 83 | 55% | ||
Total | 12,511 | Median 57% (IQR 53%-61%) | 5,915 | Median 64% (IQR 55%-72%) |
Site reported patient volume.
VL suppression (< 400 copies/mL) achieved at last visit in calendar year specified.